{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-131777","form_type":"8-K","ticker":"BCLI","cik":"0001137883","company_name":"BRAINSTORM CELL THERAPEUTICS INC.","filed_at":"2021-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.664646+00:00","generated_at":"2026-06-28T16:06:24.593762+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Brainstorm Cell Therapeutics appoints Dr. Menghis Bairu to Board; Director Sankesh Abbhi to retire","bullets":["Bairu appointed to Board effective Oct 28, 2021; receives $30K annual cash award in biannual installments.","Bairu is founder/CEO of Proxenia Venture Partners and Chairman/CEO of Bairex.","Abbhi will not stand for re-election at 2021 Annual Meeting; retirement not due to any dispute.","Abbhi served on Board since March 30, 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-131777","json":"https://secwatch.observer/filing/0001104659-21-131777.json","markdown":"https://secwatch.observer/filing/0001104659-21-131777.md","text":"https://secwatch.observer/filing/0001104659-21-131777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/0001104659-21-131777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/tm2131336d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:06:24.593762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6d7c537582","claim":"Menghisteab Bairu was elected as Director at BRAINSTORM CELL THERAPEUTICS INC..","evidence_excerpt":"the Board of Directors (the “Board”) of Brainstorm Cell Therapeutics Inc. (the “Company”) increased the size of the Board by one member and elected Dr. Menghisteab Bairu to serve as a member of the Board, effective October 28, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/0001104659-21-131777-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"855f9881e6","claim":"Sankesh Abbhi departed as Director at BRAINSTORM CELL THERAPEUTICS INC..","evidence_excerpt":"On October 27, 2021, Sankesh Abbhi informed the Board of his intention not to stand for re-election at the Company’s 2021 Annual Meeting of Stockholders (the “Annual Meeting”), and to retire from the Board effective immediately prior to the commencement of the Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/0001104659-21-131777-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election and retire"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}